J Brachial Plex Peripher Nerve Inj 2009; 04(01): e127-e132
DOI: 10.1186/1749-7221-4-17
Case report
Wang et al; licensee BioMed Central Ltd.

Serratus muscle stimulation effectively treats notalgia paresthetica caused by long thoracic nerve dysfunction: a case series[*]

Charlie K Wang
1   Department of Anesthesia, Stanford University School of Medicine, Stanford Systems Neuroscience and Pain Lab, Palo Alto, CA, USA
,
Alpana Gowda
2   Department of Anesthesia, Division of Pain Management, Stanford University School of Medicine, Stanford Pain Management Clinic, Redwood City, CA, USA
,
Meredith Barad
1   Department of Anesthesia, Stanford University School of Medicine, Stanford Systems Neuroscience and Pain Lab, Palo Alto, CA, USA
2   Department of Anesthesia, Division of Pain Management, Stanford University School of Medicine, Stanford Pain Management Clinic, Redwood City, CA, USA
,
Sean C Mackey
1   Department of Anesthesia, Stanford University School of Medicine, Stanford Systems Neuroscience and Pain Lab, Palo Alto, CA, USA
2   Department of Anesthesia, Division of Pain Management, Stanford University School of Medicine, Stanford Pain Management Clinic, Redwood City, CA, USA
,
Ian R Carroll
1   Department of Anesthesia, Stanford University School of Medicine, Stanford Systems Neuroscience and Pain Lab, Palo Alto, CA, USA
2   Department of Anesthesia, Division of Pain Management, Stanford University School of Medicine, Stanford Pain Management Clinic, Redwood City, CA, USA
› Author Affiliations

Subject Editor:
Further Information

Publication History

07 August 2009

22 September 2009

Publication Date:
18 September 2014 (online)

Abstract

Currently, notalgia paresthetica (NP) is a poorly-understood condition diagnosed on the basis of pruritus, pain, or both, in the area medial to the scapula and lateral to the thoracic spine. It has been proposed that NP is caused by degenerative changes to the T2-T6 vertebrae, genetic disposition, or nerve entrapment of the posterior rami of spinal nerves arising at T2-T6. Despite considerable research, the etiology of NP remains unclear, and a multitude of different treatment modalities have correspondingly met with varying degrees of success. Here we demonstrate that NP can be caused by long thoracic nerve injury leading to serratus anterior dysfunction, and that electrical muscle stimulation (EMS) of the serratus anterior can successfully and conservatively treat NP. In four cases of NP with known injury to the long thoracic nerve we performed transcutaneous EMS to the serratus anterior in an area far lateral to the site of pain and pruritus, resulting in significant and rapid pain relief. These findings are the first to identify long thoracic nerve injury as a cause for notalgia paresthetica and electrical muscle stimulation of the serratus anterior as a possible treatment, and we discuss the implications of these findings on better diagnosing and treating notalgia paresthetica.

*This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


 
  • References

  • 1 Misery L. What Is Notalgia paresthetica?. Dermatology 2002; 204: 86-7 10.1159/000051822 11937730
  • 2 Pleet A, Massey E. Notalgia paresthetica. Neurology 1978; 28 (12) 1310-12 569792
  • 3 Eisenberg E, Barmeir E, Bergman R. Notalgia paresthetica associated withnerve root impingement. J Am Acad Dermatol 1997; 37: 998-1000 10.1016/S0190-9622(97)70083-5 9418774
  • 4 Massey EW. Sensory Mononeuropathies. Seminars in Neurology 1998; 18 (2) 177-83 10.1055/s-2008-1040871 9608615
  • 5 Savk O, Savk E. Investigation of spinal pathology in notalgia paresthetica. J Am Acad Dermatol 2005; 52: 1085-7 10.1016/j.jaad.2005.01.138 15928634
  • 6 Streib EW, Sun SF. Notalgia paresthetica owing to Compression Neuropathy: Case Presentation Including Electrodiagnostic Studies. Eur Neurol 1981; 20: 64-7 10.1159/000115208 7202444
  • 7 Raison-Peyron N. Notalgia paresthetica: clinical, physiopathological and therapeutic aspects. A study of 12 cases. J Eur Acad Dermatol Venereol 1999; 12 (3) 215-21 10.1111/j.1468-3083.1999.tb01031.x 10461640
  • 8 Savk E. Notalgia paresthetica: a study on pathogenesis. International Journal of Dermatology 2000; 39 (10) 754-60 10.1046/j.1365-4362.2000.00080.x 11095194
  • 9 Inaloz H. Notalgia paresthetica with a significant increase in the number of intradermal nerves. J Dermatol 2002; 29 (11) 739-43 12484438
  • 10 Savk E. Immunohistochemical Findings in Notalgia paresthetica. Dermatology 2002; 204: 88-93 10.1159/000051823 11937731
  • 11 Springall DR. Symptoms of Notalgia Paresthetica May Be Explained by Increased Dermal Innervation. J Invest Dermatol 1991; 97: 555-61 10.1111/1523-1747.ep12481889 1831466
  • 12 Goulden V, Toomey PJ, Highet AS. Successful treatment of notalgia paresthetica with a paravertebral local anesthetic block. J Am Acad Dermatol 1998; 38: 114-6 10.1016/S0190-9622(98)70552-3 9448219
  • 13 Yosipovitch G, Samuel LS. Neuropathic and psychogenic itch. Dermatologic Therapy 2008; 21: 32-41 10.1111/j.1529-8019.2008.00167.x 18318883
  • 14 Leibsohn E. Treatment of notalgia paresthetica with capsaicin. Cutis 1992; 49 (5) 335-6 1521492
  • 15 Wallengren J, Klinker M. Successful treatment of notalgia paresthetica with topical capsaicin: Vehicle-controlled, double-blind, crossover study. J Am Acad Dermatol 1995; 32 (2) 287-9 10.1016/0190-9622(95)90152-3 7829721
  • 16 Stellon A. Neurogenic Pruritus: An Unrecognised Problem? A Retrospective Case Series of Treatment by Acupuncture. Acupuncture in Medicine 2002; 20 (4) 186-90 10.1136/aim.20.4.186 12512793
  • 17 Weinfeld PK. Successful Treatment of Notalgia Paresthetica With Botulinum Toxin Type A. Arch Dermatol 2007; 143 (8) 980-2 10.1001/archderm.143.8.980 17709655
  • 18 Loosemore M, Bordeaux J, Bernhard J. Gabapentin treatment for notalgia paresthetica, a common isolated peripheral sensory neuropathy. J Eur Acad Dermatol Venereol 2007; 21: 1413-50 10.1111/j.1468-3083.2007.02256.x 17958850
  • 19 Savk E. Open pilot study on oxcarbazepine for the treatment of notalgia paresthetica. J Am Acad Dermatol 2001; 45 (4) 630-2 10.1067/mjd.2001.116228 11568762
  • 20 Tacconi P. Notalgia paresthetica following neuralgic amyotrophy: a case report. Neurol Sci 2004; 25: 27-9 10.1007/s10072-004-0223-9 15060814
  • 21 Henderson J. The reinnervation pattern of wounds and scars may explain their sensory symptoms. J Plast Reconstr Aesthet Surg 2006; 59 (9) 942-50 10.1016/j.bjps.2005.11.038 16920586
  • 22 Oaklander AL. Herpes zoster itch: preliminary epidemiologic data. J Pain 2003; 4 (6) 338-43 10.1016/S1526-5900(03)00637-0 14622691
  • 23 Schmelz M. Specific C-receptors for itch in human skin. J Neurosci 1997; 17 (20) 8003-8 9315918
  • 24 Steinhoff M. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol 2003; 139 (11) 1479-88 10.1001/archderm.139.11.1479 14623709
  • 25 Weidner C. Acute effects of substance P and calcitonin gene-related peptide in human skin – a microdialysis study. J Invest Dermatol 2000; 115 (6) 1015-20 10.1046/j.1523-1747.2000.00142.x 11121135
  • 26 Schmelz M. Specific C-receptors for itch in human skin. J Neurosci 1997; 17 (20) 8003-8 9315918
  • 27 Tanaka T. Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol 1988; 90 (3) 399-401 10.1111/1523-1747.ep12456487 2450147
  • 28 Savk E, Savk O, Sendur F. Transcutaneous electrical nerve stimulation offers partial relief in notalgia paresthetica patients with a relevant spinal pathology. J Dermatol 2007; 34 (5) 315-9 17408440